Navigation Links
Allergic Reactions to Insulin Have Declined

A review of published research from the University of Liege, Belgium, reveals a decline in the number of people experiencing allergic reactions to insulin//. This is largely due to better purification of animal insulin and the introduction of human recombinant insulin.

The review also looks forward to the arrival of newly designed molecules that mimic the action of insulin while avoiding triggering an allergic response. In addition new modes of drug delivery, such as continuous subcutaneous insulin infusion (CSII), may help, and early reports suggest that CSII can help people who have previously had an allergic reaction to insulin.

In the 1950s and 1960s more than half of patients who used insulin experienced some form of allergic reaction. This has reduced considerably, but reports show that 0.1% to 3.0% of people still produce reactions that range from mild irritation to life-threatening incidents.

Originally insulin was harvested from animals, and advanced purification now makes this safer to use.

The gene for human insulin has been sequenced, and the sequence placed in bacteria. These modified organisms then produce the human insulin protein which can then be purified and used for therapy. Fewer people react to this 'recombinant insulin' because this is the human protein.

Now that scientists know the gene sequence, the shape of the insulin molecule, and the shape of the active site of the molecule, they can start to redesign it. The idea is to create a molecule that retains the action of insulin, but does not excite the human immune response system. This way it will be active, but will not cause an allergic reaction.

One potential reason for adverse reaction is that insulin is often injected in sudden doses. This gives unnaturally high peaks and troughs of the hormone. To avoid this variation, pumps have been developed that slowly infuse the hormone throughout the day. Early results on these pump
'"/>




Page: 1 2

Related medicine news :

1. Diet Can Influence Allergic Skin Reactions
2. New Treatment For People Allergic To Cats
3. Red Color Causes The Allergic Reaction To Strawberries
4. New Insight Gained For Allergic Reactions
5. Anthroposophical Lifestyle Reduces Risk Of Allergic Disease In Children
6. Allergic reaction to DTaP vaccine persists in children
7. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
8. Eye Drug Macugen Shows Allergic Reactions
9. Allergic to Kisses?
10. Preventive Measures Proved Ineffective in Allergic Children
11. New Cooperative Research Center for Allergic Disease
Post Your Comments:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
Frozen Canadian baby stages miraculous recovery
...ing their lot with the group of scientists asking ... prize winners are faxing a letter to U.S. Preside...l research in any way. The debate on stem cell res...tch with both sides slamming each other on the pro...
...dy conducted by Dr. Michael Brent, an associate pr...ersity in St. Louis, gives us an insight into the ...h a tender age.These findings were presented at th...for the advancement of science in San Francisco.Fo...
Now umbilical cord helps in stroke treatment.
Other Medicine News:
(Date:10/10/2008).../ -- TriReme Medical Inc. (TMI),announced today th...ite,Europeenne) marking and commercialize in Europ...main vessel stent system specially designed for us... the next generation in bifurcation stenting, the,...of the 2.2 million,angioplasty procedures performe...
(Date:10/9/2008)...d to protect the eyesight of,older people, NEW YO...e worldwide who,are blind, 80 percent are over age... their blindness if they had been properly diagnos...se, go to:, http://www.prnewswire.com/mnr/orbis/35...ucts and equipment, is,partnering with nonprofit O...
(Date:10/9/2008)...ovember 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-...ounced today the completion of patient enrollment ...ls to evaluate the safety and,efficacy of its form... for,the over-the-counter (OTC) market. The Compan...otal trial in November 2008. Ibuprofen is an analg...
(Date:10/9/2008)...all/ -- Diamyd Medical reports,that the world,s mo...urnal,of Medicine, has published an article with r...iabetes vaccine for type 1 diabetes., (Logo: htt...), The article is now available on the journal,s ...int on October 30. It presents the,results of the ...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Groundbreaking Canada US study proves link between emissions and mercury pollution in fish 430 1Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal 1437 1Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal 1437 2Health IT Now 21 Coalition Urges Congress to Pass Health Information Technology Bill This Year 1433 1Health IT Now 21 Coalition Urges Congress to Pass Health Information Technology Bill This Year 1433 2Health IT Now 21 Coalition Urges Congress to Pass Health Information Technology Bill This Year 1433 3Cardiome to Present at ThinkEquity Conference 1429 1Cardiome to Present at ThinkEquity Conference 1429 2Cardiome to Present at ThinkEquity Conference 1429 3
...O, Calif., April 03, 2007,/PRNewswire-FirstCall/ -...d results from its second multi-center Phase 2 tri... evaluated escalating doses,of the immunotherapy i...rostate cancer (HRPC). Additional follow-up of,the...ble to that,being employed in the company,s ongoin...
...ting of the European Association for the Study,of ...wire/ -- Pharmasset,announced today that presentat...reatment of hepatitis B (HBV) and PSI-6130, the,pa...itis C (HCV),will be made during the 42nd Annual M...f the Liver (EASL) being held in,Barcelona, Spain ...
Other Medicine Technology:Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 2Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 3Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 4
... The many benefits of fibre bronchoscopy: The HF-c...ich all other fibre bronchoscopes are measured., ...rom PENTAX, including the FB-19TV, FB-18V and FB-1...pediatric FB-8V, offer much better image quality t...
... The many benefits of fibre bronchoscopy: The HF-c...ich all other fibre bronchoscopes are measured., ...rom PENTAX, including the FB-19TV, FB-18V and FB-1...pediatric FB-8V, offer much better image quality t...
Fujinon's therapeutic fiberoptic bronchoscopes offers a generous 2.6mm operating channel with a slim outside diameter. The large channel allows for improved suction and easier passage of cytology bru
... High performance fiberoptic imaging from the late...roved its fiberscope range, focussing on providing...ced image performance. Olympus has a impressive ra...erapy in the respiratory tract to meet the demands...
Medicine Products: